|
Medixall Group Inc (CRCX) |
|
Medixall Group Inc
CRCX's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Medixall Group Inc growth rates, revenue grew
by 279.83 % in IV. Quarter 2023 from the same quarter a year ago.
Ranking at No. 1319
Railroads industry recorded
growth of revenues by 6.19 %
Medixall Group Inc net loss decreased from $-3 millions, to $-1 millions in IV. Quarter 2023,
• More on CRCX's Growth
|
|
Medixall Group Inc realized a net loss in trailing twelve months.
Medixall Group Inc realized cash reduction of $ 0 per share in trailing twelve-month period. |
Company |
-0 |
PE TTM
|
Industry |
1.08 |
PE TTM
|
|
Railroads industry's Price to Sales ratio is at 3.81.
• More on CRCX's Valuation
|
|
|
|
|
Medixall Group Inc realized net loss in trailing twelve months.
Medixall Group Inc realized cash outflow of $ 0per share in trailing twelve-month period. |
Company |
-0 |
PE TTM
|
Industry |
1.08 |
PE TTM
|
|
Railroads industry's Price to Sales ratio is at 3.81.
• More on CRCX's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com